IMPURITIES AVAILABLE FOR 'Ensifentrine'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Ensifentrine. Ensifentrine is an investigational drug that acts as a dual inhibitor of phosphodiesterase 3 (PDE3) and phosphodiesterase 4 (PDE4), offering both bronchodilator and anti-inflammatory effects. It is being developed primarily for the treatment of chronic obstructive pulmonary disease (COPD) and other respiratory conditions. Administered via inhalation, ensifentrine improves lung function by relaxing airway smooth muscles and reducing inflammation. Its dual mechanism provides a novel approach compared to existing treatments. Clinical trials have shown promising results in improving symptoms and lung capacity with a favorable safety profile. Ensifentrine is not yet approved for widespread clinical use but is in advanced stages of development. Buy high quality Ensifentrine from Omsynth Lifesciences.